You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Algeria

Jul 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Slowdown in value growth resulting from price decreases

Consumer health in Algeria continued to see solid value growth in 2011, but witnessed a slight slowdown in its value performance. This followed the expansion of standard and economy brands, whereas it used to be dominated in several categories by international premium brands. These are increasingly manufactured under license within the country, with their prices aligning with local demand.

Generalisation of automatic social security refund impacts some categories

In August 2011 the Chifa card became available to all consumers, who increasingly started switching to prescription drugs rather than OTC products in categories such as analgesics or paediatric products instead of paying a price premium. Moreover, the government switched brands from OTC to prescription, such as Sanofi-Aventis’ Rhinathiol and Toplexil, which had a strong impact on cough, cold and allergy remedies’ performance.

International brands manufactured in Algeria under license remain dominant

Groupe Saidal, leader in consumer health, manufactures several international brands under license. This results in an expansion of standard and economy products offering a level of quality recognised by consumers, who have greater trust in international names. It is also international laboratories such as Sanofi-Aventis and Novartis manufacturing domestically and offering standard brands which were the best-performing companies.

Pharmacies remain dominant channel

Pharmacies remain the leading distribution channel for all consumer health categories. Supermarkets and healthfood shops have started to gain value sales in some categories, such as weight management and sport nutrition. However, these are also considered medicinal products, and consumers prefer to receive professional advice from a pharmacist rather than self-service.

Stable and healthy value growth expected over forecast period

Consumer health is expected to witness healthy growth over the forecast period. Rising demand for prescription drugs is expected to be offset by the expansion of standard and economy brands, and in some categories, self-medication will remain widespread, made possible by the availability of affordable brands.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Algeria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Algeria, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Algeria for free:

The Consumer Health in Algeria market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Algeria?
  • What are the major brands in Algeria?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Algeria - Industry Overview

EXECUTIVE SUMMARY

Slowdown in value growth resulting from price decreases

Generalisation of automatic social security refund impacts some categories

International brands manufactured in Algeria under license remain dominant

Pharmacies remain dominant channel

Stable and healthy value growth expected over forecast period

KEY TRENDS AND DEVELOPMENTS

Domestic production increases, but shortages remain

Government encourages national manufacturer Groupe Saidal

Rising number of pharmacies losing control over phytotherapy sales

Widespread of automatic social security refund system

International media continues to influence OTC sales

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements’ registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2009-2011

SOURCES

  • Summary 2 Research Sources

Consumer Health in Algeria - Company Profiles

Bio Therapy Labs eurl in Consumer Health (Algeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

Magpharm Laboratoires in Consumer Health (Algeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Magpharm Laboratoires sarl: Competitive Position 2011

Saidal Algerie SPA in Consumer Health (Algeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Saidal Algerie SPA: Competitive Position 2011

Adult Mouth Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care witnessed healthy 5% current value terms growth in 2011. Sales remain generated by upper- and middle-income earners in large cities who are aware of the products and can afford them, as they are still available only in pharmacies, and who are conscious of dental hygiene. Lower-income consumers in rural areas continue to use traditional methods such as clove in the case of toothache, liquorice for bacteria causing bad breath, and souak, a walnut bark, for similar usage to toothbrush and toothpaste.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Algérie SPA maintained its first rank in 2011 and generated a 28% value share. The international company is present through imports of its Synthol brand. The premium product is purchased mainly by upper-income consumers who can afford such products on a regular basis, and who are more conscious of dental care issues.

PROSPECTS

  • Adult mouth care is expected to see a minor constant value CAGR of less than 1% over the forecast period. The weak rate will resulting from the limited expansion of the category, whose sales will remain generated by the same groups of consumers as low income earners are not expected to show rising interest in dental care issues. Moreover, it is only pharmacies in large cities that will continue to offer adult mouth care products, whether premium or standard brands.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Algeria - Category Analysis

HEADLINES

TRENDS

  • Analgesics saw 9% current value growth in 2011, a solid performance resulting from the constant demand for OTC medicines, particularly regarding diseases considered non-serious, and for which the majority of consumers accept pharmacists’ advice, and are not willing to book an appointment with a doctor and wait for a prescription due to the long waiting time and cost. Despite the penetration of the social security card Chifa, which enables customers not to pay at the pharmacy, many still ask for OTC analgesics without prescription.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis Algérie SPA remained the leader in OTC analgesics in 2011 holding a 27% value share. The international company, present since 2000, has a manufacturing plant in Algeria. It produces prescription medicines, vaccines, generic medicines and over-the-counter medicines. Its OTC generics are advertised on French TV, which gives it a strong advantage, particularly because Algerian consumers have a preference for French brands. The company also developed partnership with Groupe Saidal, IPA, and works with Réseau Algérien de Surveillance de la Grippe (Algerian flu surveillance network), which provides the company with greater brand recognition.

PROSPECTS

  • The analgesics environment is expected to see a 5% constant value CAGR over the forecast period. The healthy performance will result from self-medication for the treatment of many minor pains, and development of domestic production will boost sales of generic analgesics.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Algeria - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping recorded strong 10% value growth in 2011. This resulted from the development of child-specific products, as well as increased interest among upper- and middle-income earners in a category previously considered non-essential, and for which many traditional homemade alternatives are available.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratoires Boiron SA was the category leader in 2011 generating a 26% value share. The international manufacturer is present with its famous Valerian brand, available in Algeria through imports. It is due to the premium price positioning of its brand that the company was able to lead the calming and sleeping category with sales generated essentially by upper-income earners influenced by advertising on French television.

PROSPECTS

  • The calming and sleeping products category is expected to see a healthy 5% constant value CAGR over the forecast period. The category’s development will result from the expected expansion of international brands, and the development of child-specific calming and sleeping products – a category that parents would welcome when such products are advised by a doctor and pharmacist.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2006-2011
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 25 Calming and Sleeping Company Shares 2007-2011
  • Table 26 Calming and Sleeping Brand Shares 2008-2011
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Algeria - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies witnessed strong 9% value growth in 2011. It is one of the OTC categories in which self-medication is very present despite the possibility of purchasing refunded prescription products. Consumers know their symptoms and which brands they want, and try to avoid going to a doctor, as they consider colds and flu as light diseases.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saidal Algérie SPA was the category leader in 2011 and generated 44% of value sales. The domestic company manufactures several cough and cold remedies under license, such as Humex and Neo-Codion – two famous brands present and leaders for several years in Algeria.

PROSPECTS

  • The cough, cold and allergy (hay fever) remedies category is predicted to see a weak constant value CAGR of less than 1% over the forecast period. Self-medication in this category is expected to decrease sharply in coming years in favour of prescription drugs, and the government is likely to add more brands to the prescription list in order to limit abuse of self-medication products. Prices of OTC products are also expected to decline to try to maintain positive growth.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Algeria - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies saw 14% current value growth in 2011 – the strongest performance among consumer health categories. Thanks to a slight decline in unit prices, digestive remedies became affordable to all consumers, and rising health awareness led consumers to easily purchase OTC digestive remedies without a doctor’s consultation

SWITCHES

COMPETITIVE LANDSCAPE

  • Saidal Algérie SPA dominated the category in 2011 with a 41% value share. The domestic semi-public company produces several international brands under license, such as Forlax, Imodium and Proton, the best selling brand in the category. The company has been continuously encouraged by the government to increase production in order to cover domestic demand as much as possible.

PROSPECTS

  • Digestive remedies is expected to witness a solid 9% constant value CAGR over the forecast period. The steady growth is expected to be due to a development of brands and expansion of the category with more standard brands, higher domestic production and rising concerns among consumers regarding digestive problems. Additionally, increasing unhealthy food habits are likely to lead to growing digestive problems.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 37 Digestive Remedies Company Shares 2007-2011
  • Table 38 Digestive Remedies Brand Shares 2008-2011
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Ear care saw a healthy value growth of 6% in 2011. The category’s substantial increase resulted from growing demand among consumers, particularly during the summer, when ear infections develop due to the high frequentation of swimming pools and beaches. Consumers increasingly request pharmacists’ advice instead of using traditional remedies such as putting cotton with alcohol into the ear.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratoire de Diagnostic Maghrebin sarl led the category sales in 2011 with a 24% value share. The domestic company manufactures the brand Cerulyse in Algeria under license from large international company Bausch & Lomb. This remained the best-performing OTC ear care brand in 2011.

PROSPECTS

  • Ear care is predicted to see a minor 2% constant value CAGR over the forecast period. It is expected that an increasing number of consumers will use a doctor’s prescription to obtain ear treatment products, as the social security refund system became automated in the summer of 2011. The weak growth will be generated essentially by upper-income consumers willing to pay for OTC brands when experiencing minor infections.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2006-2011
  • Table 42 Sales of Ear Care: % Value Growth 2006-2011
  • Table 43 Ear Care Company Shares 2007-2011
  • Table 44 Ear Care Brand Shares 2008-2011
  • Table 45 Forecast Sales of Ear Care: Value 2011-2016
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Eye care witnessed a solid increase of approaching 6% in current value terms in 2011, generated by rising demand due to regular periods of eye infections occurring during the summer, essentially sty infections. Consumers increasingly have recourse to OTC eye care instead of trying traditional methods such as using honey or other approaches.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Algérie SPA was the key player for OTC eye care in 2011 generating a 37% value share. The international company manufactures the Vitabact brand in Algeria. It enjoys the good quality recognition of its international name and is also the product most commonly advised by pharmacists, having held first rank for several years.

PROSPECTS

  • Eye care is expected to see a slow 1% constant value CAGR over the forecast period. The rising preference for prescription eye care medicines and the presence of standard and economy brands only on an OTC basis will lead to slow value growth and limited volume increases.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2006-2011
  • Table 48 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 49 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 50 Standard Eye Care by Positioning 2007-2011
  • Table 51 Eye Care Company Shares 2007-2011
  • Table 52 Eye Care Brand Shares 2008-2011
  • Table 53 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Algeria - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products recorded 6% value growth in 2011. The category benefited from greater demand from consumers switching from homemade/traditional products and superstitious remedies but who do not want to use standard medicines, or use herbal products as a complement to standard drugs. The category also witnessed product developments which contributed to its healthy growth.

COMPETITIVE LANDSCAPE

  • Saidal Algérie SPA was the category leader in 2011 holding a 17% value share. The domestic semi-public company is present in herbal/traditional cough and cold remedies and digestive remedies.

PROSPECTS

  • The herbal/traditional products category is expected to see a constant 3% value CAGR over the forecast period. Despite the fact that prices are expected to decline and manufacturers are expected to introduce new products, the category is still expected to see minor value growth as few consumers will be aware of or interested in herbal/traditional products.

CATEGORY DATA

  • Table 55 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 56 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 57 Herbal/Traditional Products Company Shares 2007-2011
  • Table 58 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 59 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 60 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care recorded a solid 9% current value terms increase in 2011. Due to rising health awareness and buying power, the category reached a larger number of consumers for certain products such as topical antifungals, but remained limited to more affluent consumers with regard to hair loss treatments or medicated shampoos.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saidal Algérie SPA remained the category leader in 2011 with a 13% value share. The semi-public domestic company is present with brands such as Pevaryl in vaginal and topical antifungals, with the latter generating the highest value sales in medicated skin care.

PROSPECTS

  • Medicated skin care is expected to see a 4% constant value CAGR over the forecast period. The healthy performance will result from an increase in medicated skin care demand, particularly for categories where standard and economy brands are already present. Some categories will benefit from rising health and beauty awareness, such as acne treatments and medicated shampoos, but sales will remain generated only by a few upper-income consumers.

CATEGORY DATA

  • Table 61 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 62 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 63 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 64 Medicated Skin Care Brand Shares 2008-2011
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Algeria - Category Analysis

TRENDS

  • NRT smoking cessation aids remained negligible in Algeria in 2011, and many products found, such as gum, are via illegal trade.

Sports Nutrition in Algeria - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition witnessed a healthy 5% value growth in 2011 generated by a niche segment of consumers. Only imported premium brands are present in the category, available in large cities only, in a few specialised shops and pharmacies in wealthy neighbourhoods. It is only men seeking muscle gain and women using fat burn for weight loss who buy such products, and only in large cities where they are aware of their existence.

COMPETITIVE LANDSCAPE

  • Ultimate Nutrition remained the leader in 2011 with a 30% value share. The company’s brand is distributed essentially by Best Form in Algeria, but it is also the main brand found in pharmacies and has a wide range of sports nutrition products with creatine, L-carnitine and CLA, for instance.

PROSPECTS

  • Sports nutrition is expected to see a minor 2% constant value CAGR over the forecast period. The small niche of consumers, high prices and small volumes are expected to slowly grow and it is unlikely that the category will reach a greater number of consumers in coming years. Few changes are expected in this category, where there is little product visibility and brand loyalty from regular purchasers.

CATEGORY DATA

  • Table 67 Sales of Sports Nutrition: Value 2006-2011
  • Table 68 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 69 Sports Nutrition Company Shares 2007-2011
  • Table 70 Sports Nutrition Brand Shares 2008-2011
  • Table 71 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 72 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Algeria - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements was a dynamic category in 2011 and witnessed 9% value growth. Products are increasingly appreciated by consumers who seek vitamins as digestion or articulation supplements – the most demanded benefits according to pharmacists. There is also high demand from students and parents for multivitamins, anti-stress and products that aid concentration during exam periods. Demand was so high in 2011 that there were shortages in some pharmacies. However, demand for vitamins and dietary supplements remains exclusive to upper- and middle-income segments, as low-income earners cannot afford such products.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Alpharm SPA was the leader of the dietary supplements category in 2011 with a value share of 25%. The domestic manufacturer and importer is present essentially in dietary supplements, representing brands such as Elusanes and Abtei. It was followed by French company Laboratoires Juva Santé with a value share of 11% , increasingly present in the country with a large reference for its brand Juvamine in dietary supplements and vitamins.

PROSPECTS

  • The vitamins and dietary supplements category is expected to demonstrate a 5% constant value CAGR over the forecast period. The healthy performance will result from continuous demand for vitamins and dietary supplements, which will remain limited to the same upper- and middle-income consumer segments. This will lead to saturation of the category at the end of the forecast period, and price decreases are expected to lead to weaker growth.

CATEGORY DATA

  • Table 73 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 74 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 75 Dietary Supplements by Positioning 2007-2011
  • Table 76 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 77 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 78 Vitamins Brand Shares 2008-2011
  • Table 79 Dietary Supplements Brand Shares 2008-2011
  • Table 80 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 81 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Algeria - Category Analysis

HEADLINES

TRENDS

  • Weight management recorded 12% value growth in 2011, a strong performance resulting from rising awareness of health and beauty in the country, particularly among middle- and upper-income women. There are also a growing number of products available, found in more pharmacies and beauty and health specialists, giving greater visibility to weight management products. However, as prices remain high and there is no self-service in pharmacies, the category remained small in 2011.

COMPETITIVE LANDSCAPE

  • The international company Ultimate Nutrition was the key player in 2011, generating a value share of 17%. The brand is found in pharmacies and the small number of sports nutrition shops with weight loss supplements.

PROSPECTS

  • Weight management is predicted to witness an 8% constant value CAGR over the forecast period. The strong rate will result from rising demand among upper-income women increasingly concerned with health and beauty. Moreover, advertising from European and Lebanese television will increasingly influence a larger number of urban women. Such consumers are willing to pay for weight management products, which are perceived as an easy solution.

CATEGORY DATA

  • Table 82 Sales of Weight Management by Category: Value 2006-2011
  • Table 83 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 84 Weight Management Company Shares 2007-2011
  • Table 85 Weight Management Brand Shares 2008-2011
  • Table 86 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 87 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Algeria - Category Analysis

HEADLINES

TRENDS

  • Wound care saw a healthy 7% value growth in 2011, resulting from a rising number of consumers buying products from this category instead of using simple cotton or a cloth to cover a wound. This was evident in both urban and rural areas Moreover, gauze and tape are becoming increasingly affordable, and even sticking plasters are witnessing healthy growth due to more affordable prices, whereas only a few years ago only upper-income consumers could afford products in this category.

COMPETITIVE LANDSCAPE

  • Paul Hartmann Algerie sarl continued to dominate sales in 2011 with a 51% value share. The international company has been present in Algeria through the distribution of its own brands, Hartmann and Grassolind, for several years. These products are available in the majority of pharmacies. They are also widely known to consumers, who tend to remain loyal to the brands, and trust in their quality as they are also used in the hospital environment.

PROSPECTS

  • Wound care is predicted to see a 2% constant value CAGR over the forecast period. The weak rate will result from the category reaching maturity, with a large number of standard products and quality improvements for domestic brands, which are likely to satisfy all consumer groups, leading to a decline of premium brands.

CATEGORY DATA

  • Table 88 Sales of Wound Care by Category: Value 2006-2011
  • Table 89 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 90 Wound Care Company Shares 2007-2011
  • Table 91 Wound Care Brand Shares 2008-2011
  • Table 92 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 93 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!